pharmaphorum

APRIL 23, 2020

Overview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications for the healthcare ecosystem. In the global effort to proactively fight COVID-19, the webinar series has been designed to: •Provide some areas which pharma and biotech companies may wish to consider around the COVID-19 outbreak, in order to help guide our community through uncertain times •Share key healthcare impact learnings from those countries that are ahead in the COVID-19 curve •Lo

40

40

Med Ed 101

APRIL 22, 2020

Sean Navin is a clinical pharmacist who graduated in 2015 from my alma mater (University of Minnesota – Duluth). I’m excited to have him share his breakdown on Medications Targeting Pre- and Post-Prandial Glucose! You can track him down here. When managing blood glucose for patients with type 2 diabetes, it can be confusing to […].

40

40

Pharma Tutor

APRIL 21, 2020

AUTHORS : Girjesh Vishwakarma*, Dr.Surendra Kumar Jain . Sagar Institute of Research & Technology - Pharmacy. Opp. Sagar Estate, Ayodhya By Pass Road, Bhopal - 462 041 (MP). Gv1448@gmail.com. ABSTRACT : . Now a day’s usage of drugs has been increasing day by day and pharmaceutical companies are developing new drug products and humans begin taking more and effective drugs also as investigational drugs.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

Med Ed 101

APRIL 19, 2020

Omeprazole is one of the most commonly used medications for heartburn and other GI conditions. In addition to being very commonly prescribed, it is available over-the-counter which allows for widespread use throughout the public without much supervision at times. That lack of oversight may lead to an increased risk for clinically significant drug interactions.

40

40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.